Immune responses of pony foals during repeated infections of Strongylus vulgaris and regular ivermectin treatments.
Ten helminth-free pony foals divided into three groups were used in this study. Eight foals were each experimentally infected per os with 50 Strongylus vulgaris infective larvae weekly for 4 weeks, at which time one foal died of acute verminous arteritis. The remaining seven foals subsequently received 50 S. vulgaris infective larvae every 2 weeks for an additional 20 weeks. Four of the infected foals remained untreated (Group 1) and three of the infected foals were given ivermectin at 8, 16 and 24 weeks post initial infection (Group 2). Two foals served as controls (Group 3). Foals in Group 1 developed eosinophilia, which was sustained throughout the course of infection. A mild eosinophilia also developed in Group 2 foals; however, the eosinophil numbers were markedly reduced for 3 weeks after each ivermectin treatment. Only foals in Group 1 developed significant (P less than 0.05) hyperproteinemia, hyperbetaglobulinemia and a reversal of the albumin/globulin (A/G) ratio 4 weeks after initial infection. Significant (P less than 0.05) IgG anti-S. vulgaris ELISA titers developed in foals in Groups 1 and 2 3 weeks after infection and were sustained for the duration of the experiment. Western blot analysis of soluble somatic antigens of S. vulgaris adult female and male worms probed with sera from foals in Groups 1 and 2 revealed only subtle differences between these animals. The blastogenic reactivity of peripheral blood mononuclear cells (PBMC) to phytohemagglutinin and concanavalin A was not significantly different between groups. Peripheral blood mononuclear cells from foals in Groups 1 and 2 developed significant (P less than 0.05) blastogenic reactivity to S. vulgaris soluble adult somatic antigen when examined at 25 weeks after infection. Mesenteric lymph node cells from foals in Group 2, although not statistically significant, were more reactive to antigen than were the mesenteric lymph node cells from foals in Group 1 when examined at 27 weeks after infection. These results suggest that significant alterations in the immune response of ponies to S. vulgaris does not occur after intravascular killing of larvae by ivermectin treatments.
Dennis
V A
VA
Department of Veterinary Science, Louisiana State University Agricultural Center, Baton Rouge 70803.
Klei
T R
TR
Miller
M A
MA
Chapman
M R
MR
McClure
J R
JR
D000818:Animals; D000831:Animals, Newborn; D000909:Antibodies, Helminth / Q000096:biosynthesis / Q000097:blood; D000947:Antigens, Helminth / Q000276:immunology; D001797:Blood Protein Electrophoresis / Q000662:veterinary; D001798:Blood Proteins / Q000032:analysis; D015153:Blotting, Western; D004797:Enzyme-Linked Immunosorbent Assay; D004802:Eosinophilia / Q000209:etiology / Q000662:veterinary; D005260:Female; D006736:Horses; D007111:Immunity, Cellular; D007559:Ivermectin / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008297:Male; D013319:Strongyle Infections, Equine / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D013323:Strongylus / Q000276:immunology*
D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D001798:Blood Proteins; D007559:Ivermectin